Current guidelines for the management of valvular heart disease

Current guidelines for the management of valvular heart disease

Below are links to the two current guidelines for the management of valvular heart disease, the 2014 AHA/ACC guidelines and the 2012 ESC/EACTS guidelines (both available free).

The 2014 AHA/ACC guidelines restructure the classification of valvular heart disease  into “at risk,” “progressive,” “asymptomatic severe,” and “symptomatic severe”. This is designed to help clinicians determine the optimal timing of intervention. The stages take into consideration the degree of valve narrowing or leakage, the presence of symptoms, the response of the left and/or right ventricle to the valve lesion, and any change in heart rhythm.

The 2014 AHA/ACC guidelines also addresses the complex use and management of transcatheter aortic valve implantation (TAVI, also referred to as transcatheter aortic valve replacement).


About The Author

Structural Heart Disease Australia

Structural Heart Disease Australia is an incorporated association focused on education in valvular and structural cardiac diseases. It was started by group of echocardiographers, anaesthetists, clinical and interventional cardiologists, and cardiothoracic surgeons to provide a useful learning resource for medical professionals.

SHDA is supported by

Recent Tweets


Upcoming Meetings


18octAll Day20Pulmonary Hypertension Society of Australia & New Zealand (PHSANZ) ASM

18octAll Day20European Association for Cardio-Thoracic Surgery (EACTS) 32nd Annual Meeting 2018EACTS 2018

27octAll Day28ECHO Singapore 2018


01novAll Day033rd EACTS European Mechanical Circulatory Support Summit 2018EUMS 2018

08novAll Day11Australian & New Zealand Society of Cardiothoracic Surgeons (ANZSCTS) Annual Scientific Meeting 2018ANZSCTS 2018